Genetic risk factors for placental abruption: A HuGE review and meta-analysis

Epidemiology

Volumn 19, Issue 2, 2008, Pages 309-323

  Zdoukopoulos, Nikos ^a   Zintzaras, Elias ^a,b  

^a UNIVERSITY OF THESSALY   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DNA POLYMORPHISM; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HEMODYNAMICS; HUMAN; META ANALYSIS; OXIDATIVE STRESS; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOLUTIO PLACENTAE; SYSTEMATIC REVIEW; THROMBOPHILIA;

ABRUPTIO PLACENTAE; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; ODDS RATIO; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; PREGNANCY; RISK FACTORS; THROMBOPHILIA;

EID: 39149085324     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3181635694     Document Type: Review

References (109)

1. Hladky K, Yankowitz J, Hansen WF. Placental abruption. Obstet Gynecol Surv. 2002;57:299-305.
2. Gabbe SG, Niebyl JR, Simpson JL. Obstetrics: Normal and Problem Pregnancies. 3rd ed. New York: Churchill Livingstone; 1996;505-510.
3. Hurd WW, Miodovnik M, Hertzberg V, et al. Selective management of abruption placentae: a prospective study. Obstet Gynecol. 1983;61:467-473.
4. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol. 2006;108:1005-1016.
5. Ananth CV, Wilcox AJ. Placental abruption and perinatal mortality in the United States. Am J Epidemiol. 2001;153:332-337.
6. Sheiner E, Shoham-Vardi I, Hallak M, et al. Placental abruption in term pregnancies: clinical significance and obstetric risk factors. J Matern Fetal Neonatal Med. 2003;13:45-49.
7. Salihu HM, Bekan B, Aliyu MH, et al. Perinatal mortality associated with abruptio placenta in singletons and multiples. Am J Obstet Gynecol. 2005;193:198-203.
8. Ananth CV, Oyelese Y, Yeo L, et al. Placental abruption in the United States, 1979 through 2001: temporal trends and potential determinants. Am J Obstet Gynecol. 2005;192:191-198.
9. Rasmussen S, Irgens LM, Bergsjo P, et al. The occurrence of placental abruption in Norway, 1967-1991. Acta Obstet Gynecol Scand. 1996;75:222-228.
10. Saftlas AF, Olson DR, Atrash HK, et al. National trends in the incidence of abruptio placentae,1979-1987. Obstet Gynecol. 1991;78:1081-1086.
11. Ananth CV, Smulian JC, Demissie K, et al. Placental abruption among singleton and twin births in the U.S.: risk factors. Am J Epidemiol. 2001;153:771-778.
12. Paterson M. The aetiology and outcome of abruptio placentae. Acta Obstet Gynecol Scand. 1979;58:31-35.
13. Townsend RR, Laing FC, Jeffery RB. Placental abruption associated with cocaine abuse. AJR Am J Roentgenol. 1988;150:1339-1340.
14. Darby MJ, Caritis SN, Shen-Schwarz S. Placental abruption in the preterm gestation: an association with chorioamnionitis. Obstet Gynecol. 1989;74:88-92.
15. Morgan MA, Berkowitz KM, Thomas SJ, et al. Abruptio placentae: perinatal outcome in normotensive and hypertensive patients. Am J Obstet Gynecol. 1994;170:1595-1599.
16. Ananth CV, Savitz DA, Williams MA. Placental abruption and its association with hypertension and prolonged rupture of membranes: a methodological review and meta-analysis. Obstet Gynecol. 1996;88:309-318.
17. Major CA, DeVeciana M, Lewis DF, et al. Preterm premature rupture of membranes and abruptio placentae: is there an association between these pregnancy complications? Am J Obstet Gynecol. 1995;172:672-676.
18. Voigt LF, Hollenbach KA, Krohn MA, et al. The relationship of abruptio placentae with maternal smoking and small for gestational age infants. Obstet Gynecol. 1990;75:771-774.
19. Rice JP, Kay HH, Mahoney BS. The clinical significance of uterine leiomyomas in pregnancy. Am J Obstet Gynecol. 1989;160:1212-1216.
20. Ananth CV, Smulian JC, Vintzileos AM. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies. Obstet Gynecol. 1999;93:622-628.
21. Toivonen S, Heinonen S, Anttila M, et al. Reproductive risk factors, Doppler findings, and outcome of affected births in placental abruption: a population-based analysis. Am J Perinatol. 2002;8:451-459.
22. Rasmussen S, Irgens LM, Dalaker K. The effect on the likelihood of further pregnancy of placental abruption and the rate of its recurrence. Br J Obstet Gynaecol. 1997;104:1292-1295.
23. Karegard M, Gensser G. Incidence and recurrence rate of abruptio placentae in Sweden. Obstet Gynecol. 1986;67:523-528.
24. Rasmussen S, Irgens LM, Dalaker K. Outcome of pregnancies subsequent to placental abruption: a risk assessment. Acta Obstet Gynecol Scand. 2000;79:496-501.
25. De Vries JIP, Dekker GA, Huijgens PC, et al. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol. 1997;104:1248-1254.
26. Van der Molen EF, Arends GE, Nelen WL, et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy. Am J Obstet Gynecol. 2000;182:1258-1263.
27. Toivonen S, Keski-Nisula L, Saarikoski S, et al. Risk of placental abruption in first-degree relatives of index patients. Clin Genet. 2004;66:244-246.
28. Zintzaras E, Rodopoulou P, Koukoulis GN. BsmI, TaqI, ApaI and FokI polymorphisms in the vitamin D receptor (VDR) gene and the risk of osteoporosis: a meta-analysis. Dis Markers. 2006;22:317-326.
29. Zintzaras E. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet. 2006;51:618-624.
30. Whitehead A. Meta-Analysis of Controlled Clinical Trials. Chichester: Wiley; 2002.
31. Ioannidis JP, Trikalinos TA, Zintzaras E. Extreme between-study homogeneity in meta-analyses could offer useful insights. J Clin Epidemiol. 2006;59:1023-1032.
32. Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28:123-137.
33. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
34. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
35. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res. 1993;2:121-145.
36. Zintzaras E, Stefanidis I. Association between the GLUT1 gene polymorphism and the risk of diabetic nephropathy: a meta-analysis. J Hum Genet. 2005;50:84-91.
37. Zintzaras E, Hadjigeorgiou GM. Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis. J Hum Genet. 2004;49:474-481.
38. Wiener-Megnagi Z, Ben-Shlomo I, Goldberg Y, et al. Resistance to activated protein C and the Leiden mutation: high prevalence in patients with abruptio placentae. Am J Obstet Gynecol. 1998;179:1565-1567.
39. Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340:9-13.
40. Kupferminc MJ, Peri H, Zwang E, et al. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand. 2000;79:963-967.
41. Alfirevic Z, Mousa HA, Martlew V, et al. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol. 2001;97:753-759.
42. Gebhardt GS, Scholtz CL, Hillermann R, et al. Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not with intrauterine growth restriction. Eur J Obstet Gynecol Reprod Biol. 2001;97:174-177.
43. Yoshimura T, Yoshimura M, Tabata A, et al. The missence Glu298Asp variant of the endothelial nitric oxide synthase gene is strongly associated with placental abruption. Hum Genet. 2001;108:181-183.
44. Agorastos T, Karavida A, Lambropoulos A, et al. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. J Matern Fetal Neonatal Med. 2002;12:267-273.
45. Hira B, Pegoraro RJ, Rom L, et al. Polymorphisms in various coagulation genes in black South African women with placental abruption. BJOG. 2002;109:574-575.
46. Facchinetti F, Marozio L, Grandone E, et al. Thrombophilic mutations are a main risk factor for placental abruption. Haematologica. 2003;88:785-788.
47. Prochazka M, Happach C, Marsal K, et al. Factor V Leiden in pregnancies complicated by placental abruption. BJOG. 2003;110:462-466.
48. Jaaskelainen E, Toivonen S, Romppanen EL, et al. M385T polymorphism in the Factor V Gene, but not Leiden mutation is associated with placental abruption in Finnish women. Placenta. 2004;25:730-734.
49. Toivonen S, Romppanen EL, Hiltunen M, et al. Low-activity haplotype of the microsomal epoxide hydrolase gene is protective against placental abruption. J Soc Gynecol Investig. 2004;11:540-544.
50. Parle-McDermott A, Mills JL, Kirke PN, et al. MTHFD1 R653Q polymorphism is a maternal genetic risk factor for severe abruptio placentae. Am J Med Genet. 2005;132:365-368.
51. Toivonen S, Keski-Nisula L, Romppanen EL, et al. Endothelial nitric oxide synthase polymorphism is not associated with placental abruption in Finnish women. Fetal Diagn Ther. 2005;20:508-511.
52. Hillermann R, Carelse K, Gebhardt GS. The Glu298Asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in pre-eclampsia. J Hum Genet. 2005;50:415-419.
53. Dizon-Townson D, Miller C, Sibai B, et al. The relationship of the Factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol. 2005;106:517-524.
54. Jaaskelainen E, Keski-Nisula L, Toivonen S, et al. MTHFR C677T polymorphism is not associated with placental abruption or preeclampsia in Finnish women. Hypertens Pregnancy. 2006;25:73-80.
55. Zhang XQ, Craven C, Nelson L, et al. Placental abruption is more frequent in women with the angiotensinogen Thr235 mutation. Placenta. 2007;28:616-619.
56. Naidu CA, Moodley J, Pegoraro R. Methylenetetrahydrofolate (MTHFR) reductase gene polymorphism in African women with abruptio placentae. Eur J Obstet Gynecol Reprod Biol. 2007;132:241-243.
57. Jarvenpaa J, Pakkila M, Savolainen ER, et al. Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy complications in northern Finland. Gynecol Obstet Invest. 2006;62:28-32.
58. Ananth CV, Elsasser DA, Kinzler WL, et al. Polymorphisms in methionine synthase reductase and betaine- homocysteine S- methyltransferase genes: risk of placental abruption. Mol Genet Metab. 2007;91:104-110.
59. Ananth CV, Peltier MR, De Marco C, et al. Associations between 2 polymorphisms in the methylenetetrahydrofolate reductase gene and placental abruption. Am J Obstet Gynecol. 2007;197::385.e1-e7.
60. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
61. Weisberg I, Tran P, Christensen B, et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab. 1998;64:169-172.
62. Konrad C, Muller GA, Langer C, et al. Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections. J Neurol. 2004;251:1242-1248.
63. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
64. Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3 untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703.
65. Tesauro M, Thompson WC, Rogliani P, et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA. 2000;6:2832-2835.
66. Jeunemaitre X, Soubrier F, Kotelevtsev Y, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
67. Caulfield M, Lavender P, Farrall M, et al. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;330:1629-1633.
68. Hassett C, Aicher L, Sidhu JS, et al. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet. 1994;3:421-428.
69. Robien K, Ulrich CM. 5,10-methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol. 2003;157:571-582.
70. Pijnenborg R, Robertson WB, Brosens J, et al. Review article: trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. Placenta. 1981;2:71-92.
71. Stone S, Pijnenborg R, Vercruysse L, et al. The placental bed in pregnancies complicated by primary antiphospholipid symdrome. Placenta. 2006;27:457-467.
72. Kujorich JL. Thrombophilia and pregnancy complications. Am J Obstet Gynecol. 2004;191:412-424.
73. Zusterzeel PL, Peters WH, Visser W, et al. A polymorphism in the gene for microsomal epoxide hydrolase is associated with pre-eclampsia. J Med Genet. 2001;38:234-237.
74. Wang X, Wang M, Niu T, et al. Microsomal epoxide hydrolase polymorphism and risk of spontaneous abortion. Epidemiology. 1998;9:540-544.
75. Risch NJ. Searching for genetic determinants in the new millennium. Nature. 2000;405:847-856.
76. Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29:308-311.
77. Zoller B, Dahlback B. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet. 1994;343:1536-1538.
78. Kalafatis M. Coagulation factor V: a plethora of anticoagulant molecules. Curr Opin Hematol. 2005;12:141-148.
79. Van der Velden PA, Krommenhoek-Van Es T, Allaart C, et al. A frequent thrombomodulin amino acid dimorphism is not associated with thrombophilia. Thromb Haemost. 1991;65:511-513.
80. Norlund L, Holm J, Zoller B, et al. A common thrombomodulin dimorphism is associated with myocardial infarction. Thromb Haemost. 1997;77:248-251.
81. Heil SG, Lievers KJ, Boers GH, et al. Betaine- homocysteine methyltransferase (BHMT): genomic sequencing and relevance to hyperhomocysteinemia and vascular disease in humans. Mol Genet Metab. 2000;71:511-519.
82. Morin I, Platt R, Weisberg I, et al. Common variant in betainehomocysteine methyltransferase (BHMT) and risk for spina bifida. Am J Med Genet. 2003;119:172-176.
83. Bernischke K, Kaufmann P. Pathology of the Human Placenta. 4th ed. New York: Springer; 2000.
84. Dommisse J, Tiltman AJ. Placental bed biopsies in placental abruption. Br J Obstet Gynaecol. 1992;99:651-654.
85. Dorup I, Skajaa K, Sorensen KE. Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. Am J Physiol. 1999;276:H821-H825.
86. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol. 1997;272:R441-R463.
87. Williams DJ, Vallance PJ, Neild GH, et al. Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol. 1997;272:H748-H752.
88. Yoshimura M, Yasue H, Nakayama M, et al. A missence Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet. 1998;103:65-69.
89. Nurk E, Tell GS, Refsum H, et al. Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: the Hordaland Homocysteine Study. Am J Med. 2004;117:26-31.
90. McCarthy JJ, Parker A, Salem R, et al. Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes. J Med Genet. 2004;41:334-341.
91. Thomas DC, Witte JS. Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev. 2002;11:505-512.
92. Pritchard JK, Rosenberg NA. Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet. 1999;65:220-228.
93. Zintzaras E. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin Genet. 2006;69:327-336.
94. Xu J, Turner A, Little J, et al. Positive results in association studies are associated with departure from Hardy-Weinberg equilibrium: hint for genotyping error? Hum Genet. 2002;111:573-574.
95. Weir BS. Genetic Data Analysis II: Methods for Discrete Population Genetic Data. Sunderland, MA: Sinauer Associates; 1996.
96. Salanti G, Sanderson S, Higgins JP. Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med. 2005;7: 13-20.
97. Hauser MA, Li YJ, Takeuchi S, et al. Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage. Hum Mol Genet. 2003;12:671-677.
98. Kitsios G, Zintzaras E. Genetic variation associated with ischemic heart failure: a HuGE review and meta-analysis. Am J Epidemiol. 2007;166:619-633.
99. Laird NM, Lange C. Family-based designs in the age of large-scale gene-association studies. Nat Rev Genet. 2006;7:385-394.
100. Cooper RS. Gene - environment interactions and the etiology of common complex disease. Ann Intern Med. 2003;139:437-440.
101. Cordell HJ. Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. Hum Mol Genet. 2002;11:2463-2468.
102. Zintzaras E, Kitsios G, Stefanidis I. Response to endothelial nitric oxide synthase polymorphisms and susceptibility to hypertension: genotype versus haplotype analysis. Hypertension. 2007;50:557-564.
103. Zintzaras E, Koufakis T, Ziakas PD, et al. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. Eur J Epidemiol. 2006;21:501-510.
104. Zintzaras E. C677T and A1298C methylenetetrahydrofolate reductase gene polymorphisms in schizophrenia, bipolar disorder and depression: a meta-analysis of genetic association studies. Psychiatr Genet. 2006;16:105-115.
105. Zintzaras E. Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis. Psychiatr Genet. 2007;17:69-75.
106. International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299-1320.
107. Gibbs JR, Singleton A. Application of genome-wide single nucleotide polymorphism typing: simple association and beyond. PLoS Genet. 2006;2:e150.
108. Zintzaras E, Lau J. Trends in meta-analysis of genetic association studies. J Hum Genet. 2008;53:1-9.
109. Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approach. J Clin Epidemiol. 2008; in press.